Free Trial

Calian Group Ltd. (TSE:CGY) Stock Has Average Target Price of C$102.21 According to Brokerages

Calian Group logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts are broadly bullish: all 12 covering Calian Group rated it Buy or Strong Buy, with an average one-year price target of C$102.21.
  • Recent brokerage targets ranged from C$105 to C$107; shares traded at C$85.55 in Friday’s session, down 1.7%.
  • Insider Patrick Belanger Houston bought 699 shares at C$73.18 each. Calian also paid a quarterly dividend of C$0.28 per share, equivalent to an annualized yield of about 1.3%.
  • MarketBeat previews the top five stocks to own by December 1st.

Shares of Calian Group Ltd. (TSE:CGY - Get Free Report) have received a consensus recommendation of "Buy" from the twelve analysts that are presently covering the company, Marketbeat.com reports. Eleven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is C$102.21.

Several research firms recently issued reports on CGY. Scotia set a C$105.00 target price on Calian Group and gave the company a "sector outperform" rating in a research report on Friday, October 30th. Canadian Imperial Bank of Commerce lifted their price target on Calian Group from C$93.00 to C$107.00 in a research report on Friday, August 14th. Royal Bank Of Canada boosted their price target on Calian Group from C$90.00 to C$105.00 and gave the company an "outperform" rating in a research note on Friday, August 14th. Scotiabank assumed coverage on Calian Group in a research note on Friday, October 30th. They issued a "strong-buy" rating for the company. Finally, Ventum Financial set a C$106.00 target price on Calian Group and gave the stock a "buy" rating in a report on Thursday, August 27th.

View Our Latest Analysis on Calian Group

Insider Transactions at Calian Group

In other Calian Group news, insider Patrick Belanger Houston acquired 699 shares of the firm's stock in a transaction on Friday, August 28th. The stock was acquired at an average cost of C$73.18 per share, for a total transaction of C$51,152.82. Following the purchase, the insider owned 22,965 shares in the company, valued at approximately C$1,680,578.70. The trade was a 3.14% increase in their position. Corporate insiders own 0.63% of the company's stock.

Calian Group Stock Down 1.7%

Shares of CGY stock traded down C$1.48 during trading hours on Friday, reaching C$85.55. 27,064 shares of the company's stock were exchanged, compared to its average volume of 39,938. Calian Group has a 1 year low of C$44.89 and a 1 year high of C$95.50. The company has a current ratio of 1.61, a quick ratio of 1.20 and a debt-to-equity ratio of 54.28. The stock has a market cap of C$985.79 million, a PE ratio of 25.92, a PEG ratio of 2.50 and a beta of 0.61. The stock's fifty day moving average price is C$83.16 and its two-hundred day moving average price is C$78.96.

Calian Group (TSE:CGY - Get Free Report) last released its earnings results on Thursday, August 13th. The company reported C$1.10 earnings per share for the quarter. Calian Group had a net margin of 4.41% and a return on equity of 11.67%. The company had revenue of C$230.40 million for the quarter. Research analysts predict that Calian Group will post 4.95 EPS for the current year.

Calian Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 9th. Investors of record on Wednesday, September 9th were issued a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.3%. The ex-dividend date was Wednesday, August 26th. Calian Group's dividend payout ratio is 33.94%.

Calian Group Company Profile

(Get Free Report)

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

Recommended Stories

Analyst Recommendations for Calian Group (TSE:CGY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Calian Group Right Now?

Before you consider Calian Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.

While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines